SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Analysen zu SPI Healthcare-Werten
Datum | Rating | Analyst | |
---|---|---|---|
24.11.21 | Roche Neutral | UBS AG | |
24.11.21 | Roche Buy | Deutsche Bank AG | |
11.11.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
11.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
10.11.21 | Novartis Buy | Jefferies & Company Inc. | |
09.11.21 | Roche Neutral | UBS AG | |
05.11.21 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.11.21 | Novartis Neutral | UBS AG | |
04.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.21 | Novartis Underweight | JP Morgan Chase & Co. | |
04.11.21 | Roche Neutral | JP Morgan Chase & Co. | |
04.11.21 | Roche Neutral | UBS AG | |
27.10.21 | Novartis Underweight | Barclays Capital | |
27.10.21 | Novartis Sell | Deutsche Bank AG | |
27.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.10.21 | Novartis Neutral | Credit Suisse Group | |
26.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
26.10.21 | Novartis Buy | UBS AG | |
26.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
26.10.21 | Novartis Sell | Deutsche Bank AG | |
26.10.21 | Roche Buy | Deutsche Bank AG | |
25.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
25.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
25.10.21 | Novartis Buy | UBS AG | |
21.10.21 | Roche Neutral | UBS AG | |
21.10.21 | Roche Neutral | JP Morgan Chase & Co. | |
21.10.21 | Roche Neutral | Credit Suisse Group | |
20.10.21 | Roche Outperform | Bernstein Research | |
20.10.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
20.10.21 | Roche Overweight | Barclays Capital | |
20.10.21 | Roche Hold | Kepler Cheuvreux | |
20.10.21 | Roche Neutral | UBS AG | |
20.10.21 | Roche Buy | Jefferies & Company Inc. | |
20.10.21 | Roche Neutral | JP Morgan Chase & Co. | |
14.10.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.21 | Roche Outperform | Bernstein Research | |
13.10.21 | Roche Neutral | JP Morgan Chase & Co. | |
13.10.21 | Roche Equal-weight | Morgan Stanley |